Aimed at helping the global research community in its efforts to gain
(and share) new knowledge about SARS-CoV-2, Illumina (NASDAQ:ILMN) is making its SARS-CoV-2 Data Tookint available at no charge. The company says it makes its easier for researchers to identify the viral sequence.
https://seekingalpha.com/news/3561483-illumina-offering-research-toolkit-during-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.